Alan Braverman-Poyastro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alan Braverman-Poyastro has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Blanca Vianey Suárez-Rico
Community Interventions Research Branch, Instituto Nacional de Perinatología, Mexico City 11000, Mexico
1 shared publication - Enrique Reyes-Muñoz
Coordination of Gynecological and Perinatal Endocrinology, National Institute of Perinatology, Ministry of Health, México City 11000, Mexico
1 shared publication - Hector Borboa-Olivares
Community Interventions Research Branch, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, Mexico
1 shared publication - Johnatan Torres-Torres
Department of Reproductive and Perinatal Health Research Instituto Nacional de Perinatología Isidro Espinosa de los Reyes Mexico City Mexico
1 shared publication - Lidia Arce-Sánchez
Coordination of Endocrinology, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City 11000, Mexico
1 shared publication - Nayeli Martínez-Cruz
Department of Endocrinology, Instituto Nacional de Perinatología “Isidro Espinosa de los Reyes”, Montes Urales 800, Mexico City 11000, Mexico
1 shared publication
Latest Publications
- Open Access
- 5 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 313
Antepartum Fetal Surveillance and Optimal Timing of Delivery in Diabetic Women: A Narrative Review
Antepartum fetal surveillance (AFS) is essential for pregnant women with diabetes to mitigate the risk of stillbirth. However, there is still no universal consensus on the optimal testing method, testing frequency, and delivery timing. This review aims to comprehensively analyze the evidence concerning AFS and the most advantageous timing for delivery in both gestational and pregestational diabetes mellitus cases. This review’s methodology involved an extensive literature search encompassing international diabetes guidelines and scientific databases, including PubMed, MEDLINE, Google Scholar, and Scopus. The review process meticulously identified and utilized pertinent articles for analysis. Within the scope of this review, a thorough examination revealed five prominent international guidelines predominantly addressing gestational diabetes. These guidelines discuss the utility and timing of fetal well-being assessments and recommendations for optimal pregnancy resolution timing. However, the scarcity of clinical trials directly focused on this subject led to a reliance on observational studies as the basis for most recommendations. Glucose control, maternal comorbidities, and the medical management received are crucial in making decisions regarding AFS and determining the appropriate delivery timing.
- 5 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 313
Open AccessAntepartum Fetal Surveillance and Optimal Timing of Delivery in Diabetic Women: A Narrative Review
Antepartum fetal surveillance (AFS) is essential for pregnant women with diabetes to mitigate the risk of stillbirth. However, there is still no universal consensus on the optimal testing method, testing frequency, and delivery timing. This review aims to comprehensively analyze the evidence concerning AFS and the most advantageous timing for delivery in both gestational and pregestational diabetes mellitus cases. This review’s methodology involved an extensive literature search encompassing international diabetes guidelines and scientific databases, including PubMed, MEDLINE, Google Scholar, and Scopus. The review process meticulously identified and utilized pertinent articles for analysis. Within the scope of this review, a thorough examination revealed five prominent international guidelines predominantly addressing gestational diabetes. These guidelines discuss the utility and timing of fetal well-being assessments and recommendations for optimal pregnancy resolution timing. However, the scarcity of clinical trials directly focused on this subject led to a reliance on observational studies as the basis for most recommendations. Glucose control, maternal comorbidities, and the medical management received are crucial in making decisions regarding AFS and determining the appropriate delivery timing.